Methotrexate area under the curve is an important outcome predictor in patients with primary CNS lymphoma: A pharmacokinetic–pharmacodynamic analysis from the IELSG no. 20 trial
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.